HomeCompareSGEN vs SBUX

SGEN vs SBUX: Dividend Comparison 2026

SGEN yields 0.87% · SBUX yields 2.84%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SBUX wins by $146.1K in total portfolio value
10 years
SGEN
SGEN
● Live price
0.87%
Share price
$228.74
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.9K
Annual income
$92.54
Full SGEN calculator →
SBUX
SBUX
● Live price
2.84%
Share price
$86.72
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$167.0K
Annual income
$71,136.45
Full SBUX calculator →

Portfolio growth — SGEN vs SBUX

📍 SBUX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSGENSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SGEN + SBUX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SGEN pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SGEN
Annual income on $10K today (after 15% tax)
$74.32/yr
After 10yr DRIP, annual income (after tax)
$78.66/yr
SBUX
Annual income on $10K today (after 15% tax)
$241.12/yr
After 10yr DRIP, annual income (after tax)
$60,465.98/yr
At 15% tax rate, SBUX beats the other by $60,387.32/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SGEN + SBUX for your $10,000?

SGEN: 50%SBUX: 50%
100% SBUX50/50100% SGEN
Portfolio after 10yr
$94.0K
Annual income
$35,614.50/yr
Blended yield
37.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

SGEN
Analyst Ratings
14
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$171.82
-24.9% upside vs current
Range: $120.00 — $222.00
Altman Z
23.3
Piotroski
2/9
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+19.9% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SGEN buys
7
SBUX buys
0
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$SGEN▼ Sell$1,001 - $15,0002023-10-27
Josh Gottheimer🏢 House$SGEN▼ Sell$1,001 - $15,0002023-06-26
Josh Gottheimer🏢 House$SGEN▼ Sell$1,001 - $15,0002023-05-19
Daniel Goldman🏢 House$SGEN▲ Buy$1,001 - $15,0002023-03-06
Ro Khanna🏢 House$SGEN▲ Buy$1,001 - $15,0002022-12-06
Josh Gottheimer🏢 House$SGEN▼ Sell$1,001 - $15,0002022-10-17
Josh Gottheimer🏢 House$SGEN▼ Sell$1,001 - $15,0002022-02-18
Ro Khanna🏢 House$SGEN▼ Sell$1,001 - $15,0002022-02-17
Ro Khanna🏢 House$SGEN▲ Buy$1,001 - $15,0002022-01-21
Ro Khanna🏢 House$SGEN▼ Sell$1,001 - $15,0002022-01-20
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSGENSBUX
Forward yield0.87%2.84%
Annual dividend / share$2.00$2.46
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%48.3%
Portfolio after 10y$20.9K$167.0K
Annual income after 10y$92.54$71,136.45
Total dividends collected$902.00$136.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusHoldBuy
Analyst price target$171.82$104.00

Year-by-year: SGEN vs SBUX ($10,000, DRIP)

YearSGEN PortfolioSGEN Income/yrSBUX PortfolioSBUX Income/yrGap
1← crossover$10,787$87.44$11,121$420.68$334.00SBUX
2$11,631$88.15$12,548$648.40$917.00SBUX
3$12,534$88.82$14,440$1,013.98$1.9KSBUX
4$13,500$89.46$17,068$1,617.30$3.6KSBUX
5$14,536$90.05$20,912$2,649.52$6.4KSBUX
6$15,644$90.62$26,875$4,499.29$11.2KSBUX
7$16,830$91.14$36,771$8,014.12$19.9KSBUX
8$18,100$91.64$54,542$15,197.11$36.4KSBUX
9$19,459$92.11$89,602$31,242.49$70.1KSBUX
10$20,913$92.54$167,011$71,136.45$146.1KSBUX

SGEN vs SBUX: Complete Analysis 2026

SGENStock

Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. It also develops TIVDAK for metastatic cervical cancer and other solid tumors; Ladiratuzumab Vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors; Disitamab Vedotin, a novel HER2-targeted ADC; and SEA-CD40, SEA-TGT, SEA-BCMA, and SEA-CD70 for various cancer diseases. Seagen Inc. has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; Merck; and RemeGen, Co. Ltd. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington.

Full SGEN Calculator →

SBUXConsumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this SGEN vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SGEN vs SCHDSGEN vs JEPISGEN vs OSGEN vs KOSGEN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.